featured
Budesonide Oral Suspension Improves Outcomes in Eosinophilic Esophagitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results From a Phase 3 Trial
Clin. Gastroenterol. Hepatol. 2021 Apr 19;[EPub Ahead of Print], I Hirano, MH Collins, DA Katzka, VA Mukkada, GW Falk, R Morey, NK Desai, L Lan, J Williams, ES DellonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.